Navigation Links
S*BIO's Novel Dual mTOR/PI3 Kinase Inhibitor SB2343 Demonstrates Excellent PK/PD Properties Leading to Significant Anti-Tumor Efficacy in Xenograft Models
Date:2/28/2011

mouse xenograft models following once per day oral dosing.

Poster Session B (Saturday, February 26th)A novel series of tetra-substituted purines potently inhibit mTOR and PI3K, exhibit striking selectivity and demonstrate good pathway inhibition in vivo

Following structure activity relationship (SAR) investigations, SB2343 was selected for testing in vivo. A single dose of 25 mg/kg of SB2343 resulted in efficient and sustained inhibition of phosphorylation of Akt and S6 in tumor tissues. Lead optimization has resulted in the selection of SB2343 as a potent and selective orally bioavailable mTOR and pan-PI3 kinase inhibitor.

About S*BIO Pte LtdS*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's HDAC inhibitor, SB939, is currently in Phase 2 trials. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and is now completing Phase 2 trials.  It has received orphan drug designation from the U.S. and the E.U. regulatory authorities. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578 in North America and Europe. S*BIO's SB1317, a novel multikinase inhibitor, is in Phase 1 trials and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization.

In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include Bio*One Capital a subsidiary of EDBI (EDB Inve
'/>"/>

SOURCE S*BIO Pte Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Reportlinker Adds Antifungals Market to 2016 - Promising Antifungals in Pipeline Includes Novel Azoles, Polyenes and Echinocandin
2. Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions
3. ICAP Ocean Tomo Announces Patents for a New and Safer Method of Treatment of Osteoporosis and Tumor Metastasis Using a Novel Zoledronic Acid Combination
4. Tolerx Presents Preclinical Data on Novel Cancer Immunotherapeutic, TRX518, a First-in-Class Anti-GITR Antibody
5. Endo Pharmaceuticals and Orion Corporation Begin Novel R&D Collaboration
6. Novel Night Time Healing is Key to Shoulder Pain Relief From ROTATORELIEVER
7. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Targeted to Protein-Protein Binding Sites Inhibit Pancreatic Cancer Cells Growth
8. Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases
9. Pervasis Therapeutics to Develop Novel Cell-Based Approach to Target Tumor Environment, Prevent Cancer Recurrence
10. IDRI Awarded Grant from Bill and Melinda Gates Foundation to Identify Candidates for Novel TB Drugs
11. Omeros Licenses Novel Antifibrinolytic Agents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 ... new research report with market overview, trends, ... forecast, porter analysis, recent developments, competitive scenario ... Global Industry Insight: Biosensors Market Development and ... (Logo: http://photos.prnewswire.com/prnh/20150727/756778 ) Explore ...
(Date:7/30/2015)... , July 30, 2015 Takeda Pharmaceutical ... study to fulfill the post-marketing commitment and submissions ... Pan European Multi-Database Bladder Cancer Risk Characterization Study ... cohort study, conducted in four European countries, for ... up to 10 years of follow-up. Findings demonstrate ...
(Date:7/30/2015)... 30, 2015 Vermillion, Inc. (VRML), ... disease, announced today it will report its ... market close on Thursday, August 13, 2015, ... webcast at 4:30pm Eastern.Conference Call and Webcast:  ... Eastern/1:30pm Pacific  Domestic: , 888-430-8691International: ...
Breaking Medicine Technology:Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6
... address to a conference on Regional Innovation Clusters today, ... Eli Lilly and Company (NYSE: LLY ), ... innovation as a key to renewing the nation,s economy. ... of the Obama administration, at a conference co-hosted by ...
... that a new market research report is available in ... PharmaVitae Profile http://www.reportlinker.com/p0201761/Eli-Lilly--Co-PharmaVitae-Profile.html ... and forecast performance for Eli Lilly in the prescription ... and pipeline analysis and assessment of financial per ...
Cached Medicine Technology:Lilly CEO Says Regional Innovation Clusters Can Renew the Nation's Economy 2Lilly CEO Says Regional Innovation Clusters Can Renew the Nation's Economy 3Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 2Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 3Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 4Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 5Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 6Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 7
(Date:7/30/2015)... ... 30, 2015 , ... Well-known San Diego AC, plumbing and ... cost service and repair companies. For 35 years, they have grown both their ... to meet the demands of the changing technological environment. , To ...
(Date:7/30/2015)... ... July 30, 2015 , ... The need for accessibility ... effort to provide comfort to patients as well as visiting friends and family during ... phone charging stations. , The stations - powered by ChargeItSpot , a Philadelphia-based ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... of the ‘Mary Jo Lawyer-Spano Mesothelioma Patient Registry Act of 2015’. The ... (D-IL), Chris Collins (R-NY), Peter King (R-NY), Betty McCollum (D-MN), Joe Kennedy (D-MA), ...
(Date:7/30/2015)... ... July 30, 2015 , ... On July 23rd Clay Today Online ... to fund the state’s large prison system, which has amassed largely enough throughout the ... incarceration. In light of President Obama’s recent reduction of non violent drug offender’s prison ...
(Date:7/30/2015)... ... July 30, 2015 , ... The American Association ... Rosenberg’s announcement of the reinstitution of National Prescription Drug Take-Back Days. The 10th ... 10:00 AM to 2:00 PM local time. On the 26th, the DEA, with ...
Breaking Medicine News(10 mins):Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 2Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 3Health News:Hospitals Add Phone Charging Stations as an Amenity for Patients and Visitors 2Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 3Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3
... COVER: "Growing Up Bipolar" (p. 32). General Editor Mary ... have been diagnosed as,bipolar, no doubt some of them ... it,s unclear how they work, and, often, they don,t ... effects in children. Yet,untreated bipolar disorder can be disastrous; ...
... microscope at end of endoscope allows immediate imagery of ... A real-time microscopic technique called confocal laser endomicroscopy (CLE) ... disorders such as cancer, reflux disease, and inflammatory bowel ... be presented May 18 at the Digestive Disease Week ...
... Scientists have developed the first genetically altered monkey model ... disease, according to a new study funded by the ... better understand this complex, devastating and incurable genetic disorder ... 18 advance of online publication edition of Nature, could ...
... Tons of Emergency Medicines and Medical Supplies Arrives in ... ... Conn., May 18 The government of Myanmar today,cleared for entry ... AmeriCares - a nonprofit international aid,organization. The relief package will be ...
... marker found in cord blood of stressed mothers, babies , ... expectant mother is exposed to high levels of stress, her ... later in life, new research suggests. , Babies born to ... their blood at birth than did babies born to less-stressed ...
... ATS 2008, TORONTOWhen men present in emergency departments with ... and have a greater risk of dying over the ... receive, according to research from the University of Pittsburgh ... 2008 International Conference in Toronto on Tuesday, May 20. ...
Cached Medicine News:Health News:NEWSWEEK: Media Lead Sheet/May 26, 2008 Issue (on newsstands Monday, May 19, 2008) 2Health News:NEWSWEEK: Media Lead Sheet/May 26, 2008 Issue (on newsstands Monday, May 19, 2008) 3Health News:NEWSWEEK: Media Lead Sheet/May 26, 2008 Issue (on newsstands Monday, May 19, 2008) 4Health News:New Technology Speeds GI Disease Diagnosis 2Health News:New Technology Speeds GI Disease Diagnosis 3Health News:Researchers develop first transgenic monkey model of Huntington's disease 2Health News:AmeriCares Delivers Life-Saving Aid to Myanmar 2Health News:Mom's Stress in Pregnancy May Up Baby's Asthma and Allergy Risk 2Health News:Mom's Stress in Pregnancy May Up Baby's Asthma and Allergy Risk 3Health News:Gender disparity in community-acquired pneumonia 2
The PalmSAT® 2500 series are small, yet versatile digital pulse oximeters for accurate assessment of blood oxygen saturation and pulse rate. Choose alarm or non-alarm versions for your portable ...
... The WristOx® 3100 is ... designed to be worn comfortably ... for monitoring daily activities and ... design of the WristOx is ...
The Dolphin Voyager is a pulse oximetry engine designed in the standard Compact Flash format. This card slides into any Compact Flash socket and, with the accompanying Dolphin ONE software, provides ...
... the worlds first spot check monitor ... rate to use reflectance pulse oximetry ... Medicals patented technology to provide a ... for many patients and less expensive ...
Medicine Products: